▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / SEPSF

SEPSF — Asep Medical Holdings Inc.

—
OTC · Health Care · Life Sciences Tools & Services · CIK 1969766 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
ASEP Medical Holdings Inc., together with its subsidiaries, engages in the acquisition of research and development assets, technologies, and businesses in the area of life sciences and medical diagnostics. It offers peptide technologies that cover therapeutic applications, including bacterial biofilm infections, anti-inflammatory, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and medical devices with anti-microbial and antifouling coating. The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to ASEP Medical Holdings Inc. in November 2021. ASEP Medical Holdings Inc. was incorporated in 2021 and is headquartered in Victoria, Canada.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 73,177 73,177 -360,656 -273,310 8,651,858 121,295 4,593,103
Dec 2025 114,803 122,580 -744,866 -2,734,108 8,717,042 153,652 4,379,807
Sep 2025 74,803 88,642 -571,173 -486,405 13,475,042 510,627 4,086,101
Sep 2024 74,803 41,053 -811,007 -733,367 24,300,006 12,284 4,418,777

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-658,289
Investing CF
$949,373
Financing CF
$165,487
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.14
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-25,437,901
Inventory
—
Receivables
$14,750
ST Investments
—
EBIT TTM
$-1,494,163
Pretax Income TTM
$-1,501,411
Interest Exp TTM
$7,248
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$336,773
EBITDA
$-1,411,072
Free Cash Flow
$-1,152,388
Enterprise Value
$2,672,186
Total Cash
$282,028
Total Debt
$790,814
Shares Out
15,873,520
Trailing EPS
$-0.71
Book Value
$0.32
ROE
-106.3%
ROA
-11.2%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 336,773 -2,564,092 -4,915,865 8,717,042 4,379,807 — -1,017,846
Dec 2023 21,140 -7,721,263 -8,227,328 25,612,686 3,051,861 — -2,712,598
Dec 2022 0 -5,442,652 -4,524,981 27,078,589 528,161 — -3,614,476
Dec 2021 0 -1,977,625 -2,200,086 30,716,132 144,204 — -1,191,064

Peers — same industry

TickerNameMarket CapLastDaily %
IDXX IDEXX LABORATORIES INC /DE $44.46B $563.57 —
IQV IQVIA HOLDINGS INC. $34.69B $207.85 —
INCY INCYTE CORP $23.32B $116.71 —
MEDP Medpace Holdings, Inc. $15.37B $538.23 —
ICLR ICON PLC $12.94B $167.72 —

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →